Items where Author is "Tayebi, M"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 20.

Article

Tayebi, M and Jones, D R and Taylor, W A and Stileman, B F and Chapman, C and Zhao, D M and David, M (2011) PrP(Sc)-Specific Antibodies with the Ability to Immunodetect Prion Oligomers. PLoS One, 6 (5).

Jones, D R and Taylor, W A and Bate, C and David, M and Tayebi, M (2010) A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines. PLoS One, 5 (3).

Tayebi, M and David, M and Bate, C and Jones, D R and Taylor, W and Morton, R and Pollard, J and Hawke, S (2010) Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis. JOURNAL OF GENERAL VIROLOGY, 91 (Pt12). pp. 3105-3115.

Bate, C and Tayebi, M and Williams, A (2010) Glycosylphosphatidylinositol Anchor Analogues Sequester Cholesterol and Reduce Prion Formation. JOURNAL OF BIOLOGICAL CHEMISTRY, 285 (29). pp. 22017-22026.

Bate, C and Tayebi, M and Williams, A (2010) Phospholipase A(2) inhibitors protect against prion and A beta mediated synapse degeneration. Molecular Neurodegeneration, 5 (13).

Bate, C and Tayebi, M and Salmona, M and Diomede, L and Williams, A (2010) Polyunsaturated Fatty Acids Protect Against Prion-Mediated Synapse Damage In Vitro. Neurotoxicity Research, 17 (3). pp. 203-214.

Tayebi, M and Taylor, W A and Jones, D R and Bate, C and David, M (2010) PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein. JOURNAL OF GENERAL VIROLOGY, 91. pp. 2121-2131.

Bate, C and Tayebi, M and Williams, A (2010) A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A(2), synapse degeneration and neuronal death. NEUROPHARMACOLOGY, 59 (1-2). pp. 93-99.

Bate, C and Tayebi, M and Williams, A (2010) The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication. BIOCHEMICAL JOURNAL, 428. pp. 95-101.

Bate, C and Tayebi, M and Diomede, L and Salmona, M and Williams, A (2009) Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity. PLoS One, 4 (12). e8221.

Tayebi, M and Collinge, J and Hawke, S (2009) Unswitched immunoglobulin M response prolongs mouse survival in prion disease. JOURNAL OF GENERAL VIROLOGY, 90 (3). pp. 777-782.

Bate, C and Tayebi, M and Williams, A (2008) Cholesterol esterification reduces the neurotoxicity of prions. NEUROPHARMACOLOGY, 54 (8). pp. 1247-1253.

Bate, C and Tayebi, M and Diomede, L and Salmona, M and Williams, A (2008) Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells. Bmc Biology, 6.

Bate, C and Tayebi, M and Williams, A (2008) Ginkgolides protect against amyloid-beta(1-42)-mediated synapse damage in vitro. Molecular Neurodegeneration, 3 (1).

Bate, C and Tayebi, M and Williams, A (2008) Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A(2) activation. Bmc Biology, 6.

Tayebi, M and Bate, C and Hawke, S and Williams, A (2007) A role for B lymphocytes in anti-infective prion therapies? EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 5 (4). pp. 631-638.

Khalili-Shirazi, A and Quaratino, S and Londei, M and Summers, L and Tayebi, M and Clarke, A R and Hawke, S H and Jackson, G S and Collinge, J (2005) Protein conformation significantly influences immune responses to prion protein. JOURNAL OF IMMUNOLOGY, 174 (6). pp. 3256-3263.

Tayebi, M and Enever, P and Sattar, Z and Collinge, J and Hawke, S (2004) Disease-associated prion protein elicits immunoglobulin M responses in vivo. MOLECULAR MEDICINE, 10 (7-12). pp. 104-111.

Beringue, V and Vilette, D and Mallinson, G and Archer, F and Kaisar, M and Tayebi, M and Jackson, G S and Clarke, A R and Laude, H and Collinge, J and Hawke, S (2004) PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. JOURNAL OF BIOLOGICAL CHEMISTRY, 279 (38). pp. 39671-39676.

White, A R and Enever, P and Tayebi, M and Mushens, R and Linehan, J and Brandner, S and Anstee, D and Collinge, J and Hawke, S (2003) Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature, 422 (6927). pp. 80-83.

This list was generated on Thu Dec 2 07:43:15 2021 GMT.